Myocardial area at risk
Updates to Article Attributes
!under construction!
Myocardial area at risk (AAR) is defined by the ischaemic proportion of the myocardium after a coronary occlusion and reflects the potential size of the myocardial infarction 1-9.
Usage
The assessment of myocardial area at risk is an important measure in the evaluation of the potentially salvagablesalvageable myocardium by means of therapeutic approaches like coronary reperfusion 1.
Measurement
Myocardial area at risk (AAR) can be assessed by different means in cardiac magnetic resonaceresonance, including T2W/STIR imaging, T2 mapping, T1 mapping, early gadolinium enhancement, contrast-enhanced steady-state free precession and extracellular volume (ECV) imaging 9 as well with SPECT 10,11 and angiographic scores 12,13.
Interpretation
MRI
The more traditional approach to assess myocardial area at risk (AAR) with T2/STIR and more recently with T2 and T1 mapping techniques are founded on the assumption that post-infarct myocardial oedema also reflects reversibly injured myocardium respectively the area at risk (AAR) 9.
However, limitations of this approach are that the affected myocardial region is highly dynamic within the postinfarct period and myocardial oedema is not quite as stable as previously thought and influenced by cardioprotective measures, which has risen doubts about the above mentioned concept 9.
Early gadolinium enhancement, extracellular volume (ECV) imaging and contrast enhanced steady state free precession are contrast based quantificatification methods, which have been proposed as a different approach of assessing myocardial area at risk, in which the process model seems not quite clear as yet 9.
Angiography (DSA)
The modified APPROACH score, which takes site of coronary occlusion, coronary dominance, and the size of major branches into account is one means to determine area at risk, another one is the BARI score 12.
-<p>!under construction!</p><p><strong>Myocardial area at risk (AAR)</strong> is defined by the ischaemic proportion of the myocardium after a coronary occlusion and reflects the potential size of the <a href="/articles/myocardial-infarction">myocardial infarction</a> <sup>1-9</sup>.</p><h4>Usage</h4><p>The assessment of myocardial area at risk is an important measure in the evaluation of the potentially salvagable myocardium by means of therapeutic approaches like coronary reperfusion <sup>1</sup>.</p><h4>Measurement</h4><p>Myocardial area at risk (AAR) can be assessed by different means in cardiac magnetic resonace, including T2W/STIR imaging, <a href="/articles/t2-mapping-myocardium">T2 mapping</a>, <a href="/articles/t1-mapping-myocardium">T1 mapping</a>, early gadolinium enhancement, contrast-enhanced <a href="/articles/steady-state-free-precession-mri-2">steady-state free precession</a> and <a href="/articles/extracellular-volume-ecv">extracellular volume (ECV)</a> imaging <sup>9</sup> as well with SPECT <sup>10,11</sup> and angiographic scores <sup>12,13</sup>.</p><h4>Interpretation</h4><h5>MRI</h5><p>The more traditional approach to assess myocardial area at risk (AAR) with T2/STIR and more recently with <a href="/articles/t2-mapping-myocardium">T2</a> and <a href="/articles/t1-mapping-myocardium">T1 mapping</a> techniques are founded on the assumption that post-infarct <a href="/articles/myocardial-oedema">myocardial oedema</a> also reflects reversibly injured myocardium respectively the area at risk (AAR) <sup>9</sup>.</p><p>However, limitations of this approach are that the affected myocardial region is highly dynamic within the postinfarct period and <a href="/articles/myocardial-oedema">myocardial oedema</a> is not quite as stable as previously thought and influenced by cardioprotective measures, which has risen doubts about the above mentioned concept <sup>9</sup>.</p><p>Early gadolinium enhancement, <a href="/articles/extracellular-volume-ecv-myocardium">extracellular volume (ECV)</a> imaging and contrast enhanced <a href="/articles/steady-state-free-precession-mri-2">steady state free precession</a> are contrast based quantificatification methods, which have been proposed as a different approach of assessing myocardial area at risk, in which the process model seems not quite clear as yet <sup>9</sup>.</p><h5>Angiography (DSA)</h5><p>The modified APPROACH score, which takes site of coronary occlusion, <a href="/articles/coronary-arterial-dominance">coronary dominance</a>, and the size of major branches into account is one means to determine area at risk, another one is the BARI score <sup>12</sup>.</p>- +<p>!under construction!</p><p><strong>Myocardial area at risk (AAR)</strong> is defined by the ischaemic proportion of the myocardium after a coronary occlusion and reflects the potential size of the <a href="/articles/myocardial-infarction">myocardial infarction</a> <sup>1-9</sup>.</p><h4>Usage</h4><p>The assessment of myocardial area at risk is an important measure in the evaluation of the potentially salvageable myocardium by means of therapeutic approaches like coronary reperfusion <sup>1</sup>.</p><h4>Measurement</h4><p>Myocardial area at risk (AAR) can be assessed by different means in cardiac magnetic resonance, including T2W/STIR imaging, <a href="/articles/t2-mapping-myocardium">T2 mapping</a>, <a href="/articles/t1-mapping-myocardium">T1 mapping</a>, early gadolinium enhancement, contrast-enhanced <a href="/articles/steady-state-free-precession-mri-2">steady-state free precession</a> and <a href="/articles/extracellular-volume-ecv">extracellular volume (ECV)</a> imaging <sup>9</sup> as well with SPECT <sup>10,11</sup> and angiographic scores <sup>12,13</sup>.</p><h4>Interpretation</h4><h5>MRI</h5><p>The more traditional approach to assess myocardial area at risk (AAR) with T2/STIR and more recently with <a href="/articles/t2-mapping-myocardium">T2</a> and <a href="/articles/t1-mapping-myocardium">T1 mapping</a> techniques are founded on the assumption that post-infarct <a href="/articles/myocardial-oedema">myocardial oedema</a> also reflects reversibly injured myocardium respectively the area at risk (AAR) <sup>9</sup>.</p><p>However, limitations of this approach are that the affected myocardial region is highly dynamic within the postinfarct period and <a href="/articles/myocardial-oedema">myocardial oedema</a> is not quite as stable as previously thought and influenced by cardioprotective measures, which has risen doubts about the above mentioned concept <sup>9</sup>.</p><p>Early gadolinium enhancement, <a href="/articles/extracellular-volume-ecv-myocardium">extracellular volume (ECV)</a> imaging and contrast enhanced <a href="/articles/steady-state-free-precession-mri-2">steady state free precession</a> are contrast based quantificatification methods, which have been proposed as a different approach of assessing myocardial area at risk, in which the process model seems not quite clear as yet <sup>9</sup>.</p><h5>Angiography (DSA)</h5><p>The modified APPROACH score, which takes site of coronary occlusion, <a href="/articles/coronary-arterial-dominance">coronary dominance</a>, and the size of major branches into account is one means to determine area at risk, another one is the BARI score <sup>12</sup>.</p>